Patents Assigned to Entec Gesellschaft fur Endokrinologische Technologie m.b.H.
  • Use of dextran sulphate for the treatment of human prostatic carcinoma
    Patent number: 5055301
    Abstract: The invention relates to the use of dextran sulphate, optionally in combination with anti-androgen agents, for the treatment of the human prostatic carcinoma. Inhibition of the growth of both androgen-dependent and androgen-independent carcinoma cells is achieved according to the invention. The invention therefore leads to a significant improvement in the possible therapies for human prostatic carcinoma.
    Type: Grant
    Filed: January 17, 1990
    Date of Patent: October 8, 1991
    Assignee: Entec Gesellschaft fur Endokrinologische Technologie m.b.H.
    Inventors: Klaus-Dieter Voigt, Cornelius Knabbe